Cargando…
Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia–reperfusion injury?
Ischaemia–reperfusion (I/R) injury is a common feature of several diseases associated with high morbidity and mortality, such as stroke and myocardial infarction. The damaged tissue displays cardinal signs of inflammation and microvascular injury that, unless resolved, lead to long-term tissue damag...
Autor principal: | Gavins, Felicity N.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112865/ https://www.ncbi.nlm.nih.gov/pubmed/20483490 http://dx.doi.org/10.1016/j.tips.2010.04.001 |
Ejemplares similares
-
Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury
por: Cilibrizzi, Agostino
Publicado: (2018) -
Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation
por: Vital, Shantel A., et al.
Publicado: (2020) -
Correspondence: Reply to ‘Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury’
por: Qin, Cheng Xue, et al.
Publicado: (2018) -
Targeting of Formyl Peptide Receptor 2 for in vivo imaging of acute vascular inflammation
por: Boltersdorf, Tamara, et al.
Publicado: (2020) -
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice
por: Qin, Cheng Xue, et al.
Publicado: (2017)